EQL PHARMA AB (7JK) — Free Cash Flow Generation Index
Latest as of December 2025:
0.12x
EQL PHARMA AB (7JK) has a Free Cash Flow Generation Index of 0.12x as of December 2025. Free cash flow of €1.57 Million represents 0% of operating cash flow (€13.44 Million). Read total liabilities of EQL PHARMA AB for a breakdown of total debt and financial obligations.
FCF Generation Index
0.12x
Free Cash Flow / Operating CF
Free Cash Flow
€1.57 Million
EUR
Operating Cash Flow
€13.44 Million
EUR
Capital Expenditures
€11.87 Million
EUR
EQL PHARMA AB Free Cash Flow Generation Index (2022–2023)
Historical FCF Generation Index trend for EQL PHARMA AB across 2 annual periods. Explore EQL PHARMA AB (7JK) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Annual Free Cash Flow Generation for EQL PHARMA AB (2022–2023)
Year-by-year Free Cash Flow Generation Index for EQL PHARMA AB. For the full company profile including market capitalisation, see 7JK market cap.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2023 | 0.26x | €7.11 Million | €27.62 Million | €20.51 Million | ▼ -45.5% |
| 2022 | 0.47x | €19.74 Million | €41.83 Million | €22.09 Million | — |
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).